Regulatory UpdatesAug 30, 2026•1 min read

FDA Discontinues Piperazine Citrate Syrup (ANDA080774)

By the PharmaCountry team

The FDA has listed the oral syrup product Piperazine Citrate (product 001) from Alpharma US Pharms as discontinued under ANDA080774.

The U.S. Food and Drug Administration (FDA) has recorded the oral syrup product Piperazine Citrate, identified by product number 001, as discontinued. The product, marketed by Alpharma US Pharms, is an oral dosage form (syrup) containing Piperazine Citrate equivalent to 500 mg per 5 mL. It is listed under the Abbreviated New Drug Application (ANDA) number ANDA080774 and is not a reference drug or reference standard.

Compiled by the PharmaCountry team · Source: FDA.gov

Topics:#Piperazine Citrate #FDA #ANDA #discontinued #oral syrup